Presence of Trans-synaptic Neurons	1
Presence	1
Trans-synaptic Neurons	13
Olfactory Mucosa	49
Spinal Cord	85
Injury Takashi Moriwaki	97
MD	124
Koichi Iwatsuki	129
MD	147
PhD	151
Noriko Mochizuki-Oda	157
PhD	180
Yu-ichiro Ohnishi	186
MD	206
PhD	210
Masahiro Ishihara	216
MD	236
PhD	240
Masao Umegaki	246
MD	262
PhD	266
Koshi Ninomiya	272
MD	289
Toshiki Yoshimine , MD , PhD Study Design	298
dextran amine -LRB- BDA -RRB- and wheat germ agglutinin -LRB- WGA -RRB- tracers	360
dextran amine -LRB- BDA -RRB-	360
dextran amine	360
BDA	375
wheat germ agglutinin -LRB- WGA -RRB-	384
wheat germ agglutinin	384
WGA	407
tracers	412
we	421
the effectiveness of olfactory mucosa -LRB- OM -RRB- transplantation	433
the effectiveness	433
olfactory mucosa -LRB- OM -RRB- transplantation	454
OM	472
a scaffold in a rat model of chronic spinal cord injury -LRB- SCI -RRB-	495
a scaffold	495
a rat model of chronic spinal cord injury -LRB- SCI -RRB-	509
a rat model	509
chronic spinal cord injury -LRB- SCI -RRB-	524
chronic spinal cord injury	524
SCI	552
Objective .	558
We	569
OM transplantation for chronic SCI in rats	589
OM transplantation	589
chronic SCI	612
rats	627
reconstruction of neuronal pathways	643
reconstruction	643
neuronal pathways	661
both regeneration	682
the remaining axons and supply of OM-derived trans-synaptic neurons	703
the remaining axons	703
supply of OM-derived trans-synaptic neurons	727
supply	727
OM-derived trans-synaptic neurons	737
Summary of Background Data .	772
Summary	772
Background Data	783
OM	800
one of the ideal scaffolds for axonal regeneration after chronic SCI	806
one	806
the ideal scaffolds for axonal regeneration after chronic SCI	813
the ideal scaffolds	813
axonal regeneration after chronic SCI	837
axonal regeneration	837
chronic SCI	863
Methods .	877
Rats	886
a mild contusion	900
vertebral level T6 -- T7	920
vertebral level T6	920
T7	939
Two weeks after SCI	943
Two weeks	943
SCI	959
green fl	973
uorescent protein rat-derived OM	982
respiratory mucosa	1016
phosphate-buffered saline	1040
each group of SCI rats	1089
each group	1089
SCI rats	1103
Ten weeks	1113
SCI	1129
BDA	1134
the right sensorimotor cortex	1156
Eleven weeks	1187
SCI	1206
WGA	1211
the L1	1233
L2 posterior column	1240
the corticospinal tract retrogradely	1269
Twelve weeks	1330
SCI	1349
rats	1354
their spinal cords	1375
cervical -LRB- area a -RRB-	1412
cervical	1412
area a	1422
thoracic-injured -LRB- area b -RRB-	1431
thoracic-injured	1431
area b	1449
lower thoracic portions -LRB- area c -RRB-	1462
lower thoracic portions	1462
area c	1487
sections of area -LRB- b -RRB-	1519
sections	1519
area -LRB- b -RRB-	1531
area	1531
b	1537
cells	1567
enhanced green fl uorescent protein	1586
enhanced green fl	1586
4	1623
,6-diamidino-2-phenylindole , WGA , and BDA	1625
,6-diamidino-2-phenylindole	1625
WGA	1654
BDA	1663
OM and respiratory mucosa groups	1668
OM	1668
respiratory mucosa groups	1675
Axonal regenerations	1703
and BDA-positive dots	1756
transverse sections of area -LRB- a -RRB- and area -LRB- c -RRB-	1781
transverse sections	1781
area -LRB- a -RRB- and area -LRB- c -RRB-	1804
area	1804
area	1817
c	1823
Results .	1828
respiratory mucosa and phosphatebuffered saline transplantation	1851
respiratory mucosa	1851
phosphatebuffered saline transplantation	1874
OM transplantation	1916
the number	1945
WGA-positive dots	1959
area -LRB- a -RRB- , and the number of BDApositive dots in area -LRB- c -RRB-	1980
area -LRB- a -RRB-	1980
area	1980
a	1986
the number of BDApositive dots in area -LRB- c -RRB-	1994
the number	1994
BDApositive dots in area -LRB- c -RRB-	2008
BDApositive dots	2008
area -LRB- c -RRB-	2028
area	2028
c	2034
OM transplantation	2052
phosphate-buffered saline transplantation	2082
the number of quadruple-positive cells in area -LRB- b -RRB-	2138
the number	2138
quadruple-positive cells in area -LRB- b -RRB-	2152
quadruple-positive cells	2152
area -LRB- b -RRB-	2180
area	2180
b	2186
OM transplantation	2211
Conclusion .	2232
Our results	2244
indirect and direct evidence	2269
the presence of trans-synaptic neurons	2302
the presence	2302
trans-synaptic neurons	2318
OM transplantation in rats with chronic SCI	2342
OM transplantation	2342
rats with chronic SCI	2364
rats	2364
chronic SCI	2374
reconstruction of neural pathways	2398
reconstruction	2398
neural pathways	2416
both	2435
trans-synaptic neurons	2450
regeneration of remaining axons	2488
regeneration	2488
remaining axons	2504
The olfactory mucosa	2521
an effi cacious scaffold	2559
the relay neuron	2595
chronic spinal cord injury	2615
Spinal cord injury -LRB- SCI -RRB-	2643
Spinal cord injury	2643
SCI	2663
severe , irreversible damage that leads to partial or complete loss of motor	2703
severe , irreversible damage	2703
partial or complete loss of motor	2745
partial or complete loss	2745
motor	2773
sensory functions in regions	2783
sensory functions	2783
regions	2804
the level of the SCI	2822
the level	2822
the SCI	2835
Severe SCI	2844
the loss of an entire neuron or the tissue	2869
the loss	2869
an entire neuron or the tissue	2881
an entire neuron	2881
the tissue	2901
the site of injury	2915
the site	2915
injury	2927
the function and structure of the spinal cord	2953
the function and structure	2953
the spinal cord	2983
appropriate cell or tissue transplantation therapies	3000
Cell or tissue loss due to SCI	3076
Cell or tissue loss	3076
SCI	3103
the extracellular matrix that induces neuronal degeneration	3119
the extracellular matrix	3119
neuronal degeneration	3157
ideal scaffolds for SCI repair	3187
ideal scaffolds	3187
SCI repair	3207
These scaffolds	3242
the following characteristics	3268
good biocompatibility	3299
ideal degradation and formation rates	3322
suitable mechanical properties	3365
1	3397
There	3399
many acellular scaffolds	3409
collagen fi laments	3439
agarose	3460
Matrigel	3472
Becton , Dickinson and Company , Franklin Lakes , NJ	3482
Becton , Dickinson and Company	3482
Franklin Lakes	3513
NJ	3529
scaffolds	3533
2	3544
an immunological perspective	3551
autologous transplantation for SCI	3581
autologous transplantation	3581
SCI	3612
many advantages	3620
example	3641
the use of autologous olfactory mucosa -LRB- OM -RRB- transplants	3650
the use	3650
autologous olfactory mucosa -LRB- OM -RRB- transplants	3661
cellular bridge	3720
this	3737
surgeons	3757
OM tissue	3775
relatively simple endoscopic techniques	3807
3 Lima et al , as well as our group ,	3848
3 Lima et al	3848
3 Lima	3848
et al	3855
our group	3874
grafts of the OM 4 -- 6	3899
grafts	3899
the OM 4 -- 6	3909
the OM	3909
4 -- 6	3916
functional recovery	3953
spinal cord injury	3979
animals	4001
histological evidence	4014
neuronal regeneration 3 , 5 , 7 -- 10 and in clinical research	4039
neuronal regeneration 3	4039
5	4065
7 -- 10	4069
in clinical research	4078
8 , 11 Transplantation of OM tissue	4100
8	4100
11 Transplantation of OM tissue	4104
11 Transplantation	4104
OM tissue	4126
remyelination , 5 , 12 -- 15 axonal regeneration , 5 , 12 , 15 -- 19	4149
remyelination	4149
5	4164
12 -- 15 axonal regeneration , 5 , 12 , 15 -- 19	4168
12	4168
15 axonal regeneration , 5 , 12 , 15	4171
15 axonal regeneration	4171
5	4195
12	4199
15	4204
19	4207
a suitable cell bridge scaffold	4221
3	4254
17	4258
19 -- 22	4263
These changes	4269
axonal function	4312
an anterograde tract tracer	4342
axonal regenerations from slightly rostral neurons	4371
axonal regenerations	4371
slightly rostral neurons	4397
3 , 7	4438
3	4438
7	4442
it	4453
addition	4476
axonal regeneration	4488
trans-synaptic regeneration	4509
Trans-synaptic neurons derived from OM tissue	4556
Trans-synaptic neurons	4556
OM tissue	4592
the disrupted neuronal circuits	4628
relays	4672
signals	4697
superior endogenous neurons or axons and inferior ventral horn neurons	4713
superior endogenous neurons or axons	4713
inferior ventral horn neurons	4754
23	4785
this study	4791
we	4803
the presence of OM	4815
the presence	4815
OM	4831
trans-synaptic regeneration 23 and relay-neurons	4852
trans-synaptic regeneration 23	4852
relay-neurons	4887
rats that were subjected to a spinal cord contusion protocol	4904
rats	4904
a spinal cord contusion protocol	4932
Rat tissue	4966
a dual-tracing technique 24	4997
the anterograde tracer	5036
dextran amine -LRB- BDA -RRB-	5072
dextran amine	5072
BDA	5087
the retrograde trans-synaptic tracer wheat germ agglutinin -LRB- WGA -RRB-	5096
the retrograde trans-synaptic tracer wheat germ agglutinin	5096
WGA	5156
21 , 25 , 26 MATERIALS	5162
METHODS Animals Sixteen adult male Sprague-Dawley rats	5190
METHODS Animals	5190
Sixteen adult male Sprague-Dawley rats	5206
8-week old ; SRL Inc. , Hamamatsu , Japan	5246
8-week old	5246
SRL Inc. , Hamamatsu , Japan	5258
the study	5299
All rats	5310
food and water ad libitum	5330
a 12-hour lightdark cycle in a standard cage	5368
a 12-hour lightdark cycle	5368
a standard cage	5397
the study	5424
All protocols for animal procedures	5435
All protocols	5435
animal procedures	5453
the the guidelines	5488
the Laboratory Animals Care and Use Committee	5510
the Osaka University Faculty of Medicine Spinal Cord	5559
the Osaka University Faculty	5559
Medicine Spinal Cord	5591
Injury All rats	5612
gas anesthetized	5633
isofl urane	5653
their heads	5673
a stereotaxic frame -LRB- SR-5R ; Narishige , Japan -RRB-	5699
a stereotaxic frame	5699
SR-5R ; Narishige , Japan	5720
SR-5R	5720
Narishige , Japan	5727
Total laminectomy	5746
the T6 -- T7 spinal cord level	5788
the T6	5788
T7 spinal cord level	5796
T7	5796
spinal cord level	5799
the dorsal surface of the T6 -- T7 dura mater	5824
the dorsal surface	5824
the T6 -- T7 dura mater	5846
the T6	5846
T7 dura mater	5853
the cord	5880
a SCI device	5913
150 kdyn	5927
= 1.5 N -LRB- newton -RRB- , for 5 s ; IH-0400 Impactor , PSI , Virginia , USA	5936
= 1.5 N -LRB- newton -RRB- , for 5 s	5936
= 1.5 N -LRB- newton -RRB-	5936
= 1.5 N	5936
1.5	5938
newton	5945
5 s	5958
IH-0400 Impactor , PSI , Virginia , USA	5963
The muscle and skin	6002
5-0 Prolene -LRB- ETHICON , New Jersey , USA -RRB-	6040
5-0 Prolene	6040
ETHICON	6053
New Jersey	6062
USA	6074
All rats	6080
an oxazepam	6113
a dose 5 mg/day -LRB- Monday to Thursday -RRB- or 10 mg/day -LRB- Friday -RRB-	6128
a dose 5 mg/day	6128
Thursday	6155
10 mg/day	6168
Friday	6179
manual bladder evacuation	6201
they	6233
Functioning of hind limb movements	6260
Functioning	6260
hind limb movements	6275
Basso , Beattie , and Bresnahan	6315
locomotor rating scale scores once per week	6345
locomotor rating scale scores	6345
week	6384
up to 10 weeks	6393
SCI	6414
One week	6419
SCI	6434
no hind limb movements	6439
any of the rats -LRB- Basso , Beattie , and Bresnahan scale score : 0 or 1 -RRB-	6479
any	6479
the rats -LRB- Basso , Beattie , and Bresnahan scale score : 0 or 1 -RRB-	6486
the rats	6486
Basso , Beattie , and Bresnahan scale score : 0 or 1	6496
Basso	6496
Beattie	6503
Bresnahan scale score : 0 or 1	6516
Bresnahan scale score	6516
0 or 1	6539
Ten weeks after SCI , Basso , Beattie ,	6548
Ten weeks	6548
SCI , Basso , Beattie ,	6564
Bresnahan scale scores	6589
the respiratory mucosa -LRB- RM -RRB-	6615
the respiratory mucosa	6615
RM	6639
OM	6644
phosphate-buffered saline -LRB- PBS -RRB- groups	6652
PBS	6679
8.37 ± 0.498 , 7.75 ± 0.423 , and 6.37 ± 0.962	6696
8.37 ± 0.498	6696
8.37	6696
0.498	6703
7.75 ± 0.423	6710
7.75	6710
0.423	6717
6.37 ± 0.962	6728
6.37	6728
0.962	6735
There	6756
no indication of signifi	6766
no indication	6766
signifi	6783
cant differences between the motor function recovery of OM , RM	6793
cant differences	6793
the motor function recovery of OM , RM	6818
the motor function recovery	6818
OM , RM	6849
OM	6849
RM	6853
PBS rats in this study	6861
PBS rats	6861
this study	6873
Preparation	6885
the Olfactory and Respiratory Mucosa The OM and RM for transplantation	6900
the Olfactory and Respiratory Mucosa The OM	6900
the Olfactory and Respiratory Mucosa	6900
The OM	6937
RM for transplantation	6948
RM	6948
transplantation	6955
3 , 7 The transgenic rats	7011
3	7011
7 The transgenic rats	7015
7	7015
The transgenic rats	7017
the enhanced green fl	7043
uorescent protein -LRB- EGFP -RRB-	7065
uorescent protein	7065
EGFP	7084
gene driven by the ubiquitously expressed CAG promoter	7090
gene	7090
the ubiquitously expressed CAG promoter	7105
27 Briefl y , age-matched syngeneic EGFP rats	7146
27 Briefl y	7146
age-matched syngeneic EGFP rats	7159
overdose intraperitoneal injection	7212
the cranial bone	7252
2 portions longitudinally	7280
2 portions	7280
the midline nasal septum with the membrane	7313
the midline nasal septum	7313
the membrane	7343
The nasal septum	7357
each turbinate	7391
microforceps	7426
cold serum-free Dulbecco 's Modifi ed Eagle 's Medium	7453
cold	7453
serum-free Dulbecco 's Modifi	7458
serum-free Dulbecco 's	7458
Eagle 's Medium	7490
Eagle 's	7490
The OM	7506
the caudal part of the septum	7528
the caudal part	7528
the septum	7547
the RM	7567
the anterodorsal part of the septum	7581
the anterodorsal part	7581
the septum	7606
addition	7621
there	7631
the color difference between OM and RM	7641
the color difference	7641
OM and RM	7670
OM	7670
RM	7677
the OM	7681
yellowish and RM grayish	7692
the microscope	7724
the OM and RM	7740
each side of the septum using microforceps	7772
each side	7772
the septum using microforceps	7785
the septum	7785
microforceps	7802
forceps and microscissors	7822
the tissues	7849
0.5-mm squares	7875
serum-free , ice-cold Dulbecco 's Modifi	7910
Dulbecco 's	7931
Eagle 's Medium	7952
Eagle 's	7952
transplantation	7973
Fourteen days	8006
SCI	8026
rats	8031
the injured area	8058
the microscope	8107
scar tissue	8123
the extensively injured area including rostral to caudal uninjured spinal cord	8151
the extensively injured area	8151
rostral to caudal uninjured spinal cord	8190
rostral	8190
caudal uninjured spinal cord	8201
The posterior median sulcus of the extensively injured area	8243
The posterior median sulcus	8243
the extensively injured area	8274
the rostral	8320
caudal side	8335
microforceps	8354
six 0.5-mm square fragments	8368
OM or RM obtained from EGFP rats , or 5 μ L of PBS	8399
OM or RM obtained from EGFP rats	8399
OM or RM	8399
EGFP rats	8422
5 μ L of PBS	8436
5 μ L	8436
PBS	8445
the posterior median sulcus of the extensively injured area	8467
the posterior median sulcus	8467
the extensively injured area	8498
The OM or RM from 1 EGFP rat	8528
The OM or RM	8528
1 EGFP rat	8546
2 rats with SCI	8579
2 rats	8579
SCI	8591
Experimental rats	8596
OM fragments -LRB- OM group , n = 8 -RRB-	8623
OM fragments	8623
OM group , n = 8	8637
OM group	8637
n = 8	8647
n	8647
8	8651
control rats	8663
RM fragments	8685
RM group , n = 4	8699
RM group	8699
n = 4	8709
n	8709
4	8713
5 μ L of PBS -LRB- PBS group , n = 4 -RRB-	8719
5 μ L	8719
PBS -LRB- PBS group , n = 4 -RRB-	8728
PBS	8728
PBS group , n = 4	8733
PBS group	8733
n = 4	8744
n	8744
4	8748
There	8752
3 experimental groups ; 1 treated by OM and 1 by RM and 1 control groups	8763
3 experimental groups	8763
1 treated by OM and 1 by RM and 1 control groups	8786
1	8786
OM and 1	8799
OM	8799
1	8806
RM and 1 control groups	8811
RM	8811
1 control groups	8818
All rats	8836
5 mg of cyclosporine and 5 mg of oxazepam every day	8869
5 mg of cyclosporine	8869
5 mg	8869
cyclosporine	8877
5 mg of oxazepam every day	8894
5 mg	8894
oxazepam every day	8902
oxazepam	8902
every day	8911
Monday to Thursday and 10 mg of both drugs on Friday	8926
Monday to Thursday	8926
Monday	8926
Thursday	8936
10 mg of both drugs on Friday	8949
10 mg	8949
both drugs on Friday	8958
both drugs	8958
Friday	8972
12 weeks	8985
SCI	9000
Anterograde	9005
the Corticospinal Tracts	9029
BDA Ten weeks	9060
SCI , the descending corticospinal tract fi bers	9080
SCI	9080
the descending corticospinal tract fi bers	9085
BDA 7	9146
10 % BDA in PBS	9153
10 % BDA	9153
PBS	9164
molecular weight 10,000 ; Invitrogen , California USA	9169
molecular weight 10,000	9169
Invitrogen , California USA	9194
The rats	9223
their heads	9255
a stereotaxic frame	9285
a microscope	9324
the right skull over the sensorimotor area	9338
the right skull	9338
the sensorimotor area	9359
10 % BDA -LRB- total 5.0 μ L -RRB-	9397
10 % BDA	9397
total 5.0 μ L	9406
the right sensorimotor cortex	9439
3 points	9472
bregma : anterior/lateral ; 0 mm/2 mm , 2 mm/2 mm , and − 2 mm/2 mm	9499
bregma	9499
anterior/lateral	9507
0 mm/2 mm	9525
2 mm/2 mm	9536
− 2 mm/2 mm	9551
a depth of 0.5 mm	9584
a depth	9584
0.5 mm	9595
a glass	9609
a Hamilton microsyringe -LRB- Hamilton Company , Nevada , USA -RRB-	9639
a Hamilton microsyringe	9639
Hamilton Company	9664
Nevada	9682
USA	9690
7	9696
28	9700
Trans-synaptic Neuronal Pathways	9715
WGA	9754
The WGA protein	9758
a trans-synaptic neuronal tracer in both anterograde and retrograde directions	9777
a trans-synaptic neuronal tracer	9777
both anterograde and retrograde directions	9813
anterograde	9818
retrograde directions	9834
1 neuron	9874
another neuron via synapses	9886
another neuron	9886
synapses	9905
the labeling of neuronal pathways	9928
the labeling	9928
neuronal pathways	9944
Eleven weeks	9963
SCI	9982
trans-synaptic neuronal pathways	9987
lumbar spinal cord in the retrograde direction	10025
lumbar spinal cord	10025
the retrograde direction	10047
WGA 25 , 26 , 29 , 30	10090
WGA 25	10090
26	10099
29	10104
30	10109
1 % WGA in PBS	10113
1 % WGA	10113
PBS	10123
total 6.0 μ L per lumbar spinal cord ; Invitrogen	10128
total 6.0 μ L	10128
lumbar spinal cord ; Invitrogen	10146
lumbar spinal cord	10146
Invitrogen	10166
the rats	10188
their heads	10219
a stereotaxic frame	10249
the L1 -- L2 lumbar spinal cord	10285
the L1	10285
L2 lumbar spinal cord	10292
L2	10292
lumbar spinal cord	10295
1 % WGA in PBS -LRB- total 7.0 μ L -RRB-	10315
1 % WGA in PBS	10315
1 % WGA	10315
PBS	10325
total 7.0 μ L	10330
the L1	10362
L2 dorsal column	10369
the lumbar spinal cord	10389
3 points	10415
L1 median : anterior ; 0 mm , 2 mm , and − 2 mm	10442
L1 median	10442
anterior	10453
0 mm	10463
2 mm	10469
− 2 mm	10479
a depth of 0.5 mm	10507
a depth	10507
0.5 mm	10518
a glass	10532
a Hamilton microsyringe	10562
28	10587
differences in each axonal transport speed	10601
differences	10601
each axonal transport speed	10616
WGA and BDA	10645
a different week	10674
This	10692
a minimally invasive surgery for rats	10708
a minimally invasive surgery	10708
rats	10741
a result	10749
Histological Processing	10759
the Spinal Cord	10786
Twelve weeks	10802
SCI -LRB- Figure	10821
rats	10839
overdose intraperitoneal injection	10865
the left ventricle	10921
4 % paraformaldehyde in 0.1 M PBS	10945
4 % paraformaldehyde	10945
0.1 M PBS	10968
The whole spinal cord including T6 -- T7	10979
The whole spinal cord	10979
T6 -- T7	11011
T6	11011
T7	11014
postfi xed	11030
overnight	11041
the same fi	11054
30 % sucrose	11095
4 ° C for 72 hours	11110
4 ° C	11110
72 hours	11120
The whole spinal cord	11130
4 parts	11169
the cervical -LRB- area a -RRB-	11191
the cervical	11191
area a	11205
thoracic-injured -LRB- area b -RRB-	11214
thoracic-injured	11214
area b	11232
area c	11257
WGA injection -LRB- area d -RRB- regions	11270
WGA injection	11270
area d	11285
regions	11293
The area -LRB- c -RRB-	11302
The area	11302
c	11312
the midpoint	11328
the epicenter	11349
area -LRB- b -RRB- and the WGA injection point -LRB- area d ; Figure 2 -RRB-	11366
area	11366
b	11372
the WGA injection point	11379
area d ; Figure 2	11404
area d	11404
Figure 2	11412
The center of the cervical cords -LRB- area a -RRB-	11424
The center	11424
the cervical cords -LRB- area a -RRB-	11438
the cervical cords	11438
area a	11458
25 mm	11482
the epicenter	11493
the transverse plane	11511
three 2-mm thick sections	11560
The thoracic-injured cords -LRB- area b -RRB-	11587
The thoracic-injured cords	11587
area b	11615
the epicenter	11639
the transverse plane	11656
fi ve 2-mm	11705
fi	11705
ve 2-mm	11708
thick sections	11716
The lower thoracic cords -LRB- area c -RRB- around the midpoint	11732
The lower thoracic cords -LRB- area c -RRB-	11732
The lower thoracic cords	11732
area c	11758
the midpoint	11773
the transverse plane	11798
three 2-mm thick sections -LRB- Figure 2 -RRB-	11848
three 2-mm thick sections	11848
Figure 2	11876
there	11891
TissueTek -LRB- Sakura Finetek , Japan -RRB-	11914
TissueTek	11914
Sakura Finetek	11925
Japan	11941
All these transverse cord sections	11948
the transverse plane with a cryostat at 10 - μ m thickness	12004
the transverse plane	12004
a cryostat at 10 - μ m thickness	12030
a cryostat at 10	12030
a cryostat	12030
10	12044
μ m thickness	12048
The prepared specimens	12063
room temperature for 30 minutes	12100
room temperature	12100
30 minutes	12121
PBS	12152
the tissues	12157
Dako Pen -LRB- Dako , Glostrup , Denmark -RRB-	12185
Dako Pen	12185
Dako	12195
Glostrup	12201
Denmark	12211
0.3 % Triton X-100 -LRB- Sigma-Aldrich , St. Louis , USA -RRB-	12238
0.3 % Triton X-100	12238
Sigma-Aldrich	12257
St. Louis	12272
USA	12283
PBS	12291
1 % bovine serum albumin	12306
room temperature for 4 hours	12333
room temperature	12333
4 hours	12354
PBS	12382
these	12387
2 hours at room temperature	12412
2 hours	12412
room temperature	12423
streptavidin -LRB- Alexa Fluor 546 conjugate , 1:400 in PBS ; Invitrogen -RRB-	12445
streptavidin	12445
Alexa Fluor 546 conjugate , 1:400 in PBS ; Invitrogen	12459
Alexa Fluor	12459
546 conjugate , 1:400 in PBS ; Invitrogen	12471
546 conjugate	12471
1:400 in PBS ; Invitrogen	12486
1:400 in PBS	12486
1:400	12486
PBS	12495
Invitrogen	12500
the WGA tracer	12517
WGA-Alexa Fluor 633 conjugate -LRB- Invitrogen -RRB-	12533
WGA-Alexa Fluor 633 conjugate	12533
WGA-Alexa Fluor	12533
633 conjugate	12549
Invitrogen	12564
the tissues	12595
with 4 ' ,6-diamidino - 2-phenylindole -LRB- DAPI -RRB-	12627
4	12632
,6-diamidino - 2-phenylindole -LRB- DAPI -RRB-	12634
,6-diamidino	12634
2-phenylindole -LRB- DAPI -RRB-	12648
2-phenylindole	12648
DAPI	12664
All the sections	12671
a confocal laser-scanning microscope	12708
Olympus FluoView FV1000-D ; Olympus , Tokyo , Japan	12746
Olympus FluoView FV1000-D	12746
Olympus , Tokyo , Japan	12773
The BDA and WGApositive cells	12797
tally counter	12858
STATISTICAL ANALYSIS The number of BDA and WGA-positive cells	12873
STATISTICAL ANALYSIS The number	12873
STATISTICAL ANALYSIS	12873
The number	12894
BDA and WGA-positive cells	12908
BDA	12908
WGA-positive cells	12916
1-way analysis of variance	12954
1-way analysis	12954
variance	12972
the Tukey-Kramer test -LRB- Figure 3E , F -RRB-	12986
the Tukey-Kramer test	12986
Figure 3E , F	13010
Figure 3E	13010
F	13021
The number of relay-neurons between the OM and RM groups	13026
The number	13026
relay-neurons between the OM and RM groups	13040
relay-neurons	13040
the OM and RM groups	13062
the Student t test -LRB- Figure 4C -RRB-	13102
the Student t test	13102
Figure 4C	13123
Data	13136
the mean ± standard error of the mean	13158
the mean ± standard error	13158
the mean	13187
Statistical signifi cance	13197
P	13234
RESULTS Figure 1 .	13245
RESULTS	13245
Figure 1	13253
Timeline	13263
the OM	13275
RM transplantation 14 days after spinal cord injury and BDA	13283
RM transplantation	13283
14 days	13302
spinal cord injury and BDA	13316
spinal cord injury	13316
BDA	13339
WGA injection protocol	13344
OM	13368
olfactory mucosa	13381
BDA , biotinylated dextran amine	13399
BDA	13399
dextran amine	13417
WGA , wheat germ agglutinin	13432
WGA	13432
wheat germ agglutinin	13437
RM , respiratory mucosa	13460
RM	13460
respiratory mucosa	13464
SCI , spinal cord injury	13484
SCI	13484
spinal cord injury	13489
BBB , Basso , Beattie , and Bresnahan	13509
BBB , Basso , Beattie ,	13509
Bresnahan	13534
Figure 3 .	13546
Figure	13546
3	13553
A , B , Anterograde labeling of axons	13556
A , B , Anterograde labeling	13556
B	13560
axons	13588
BDA	13609
Figure 3A	13614
typical BDA-positive labeling	13630
area -LRB- a -RRB- , whereas Figure 3B shows area -LRB- c -RRB- of OM rats	13663
area	13663
-LRB- a -RRB- , whereas Figure 3B shows area -LRB- c -RRB- of OM rats	13668
Figure 3B	13683
area -LRB- c -RRB- of OM rats	13699
area -LRB- c -RRB-	13699
area	13699
c	13706
OM rats	13713
The white dotted line	13722
the dorsal column	13754
the dorsal column	13776
the yellow square	13795
high magnifi cation of BDA-positive dots	13819
high magnifi cation	13819
BDA-positive dots	13842
Scale	13861
200 μ m/50	13873
μ m -LRB- high magnifi cation -RRB-	13884
μ m	13884
high magnifi cation	13889
high magnifi	13889
cation	13902
C	13911
D	13915
Retrograde labeling	13919
axons including trans-synaptic pathways obtained using WGA	13942
axons	13942
trans-synaptic pathways obtained using WGA	13958
trans-synaptic pathways	13958
WGA	13997
Figure 2C	14002
typical WGA-positive labeling	14018
area -LRB- a -RRB- , whereas Figure 2D shows area -LRB- c -RRB- of OM rats	14051
area	14051
-LRB- a -RRB- , whereas Figure 2D shows area -LRB- c -RRB- of OM rats	14056
Figure 2D	14069
area -LRB- c -RRB- of OM rats	14085
area -LRB- c -RRB-	14085
area	14085
c	14091
OM rats	14097
The white dotted line	14106
the posterior column	14138
the dorsal column	14163
the yellow square	14182
high magnifi cation of WGA-positive dots	14206
high magnifi cation	14206
WGA-positive dots	14229
Scale	14248
200 μ m/50	14260
μ m -LRB- high magnifi cation -RRB-	14271
μ m	14271
high magnifi cation	14276
high magnifi	14276
cation	14289
3E	14298
The number	14303
anterograde tracer BDA-positive dots at area -LRB- c -RRB-	14325
anterograde tracer BDA-positive dots	14325
area	14365
c	14371
, Figure 3B -RRB-	14381
3B	14390
which	14396
the epicenter	14417
RM -LRB- n = 9 -RRB- , OM -LRB- n = 18 -RRB- , and PBS -LRB- n = 9 -RRB- groups	14434
RM -LRB- n = 9 -RRB-	14434
RM	14434
n	14438
9	14442
OM -LRB- n = 18 -RRB-	14446
OM	14446
n	14450
18	14454
PBS -LRB- n = 9 -RRB- groups	14463
PBS	14463
n	14468
9	14472
groups	14475
5.22 ± 1.07	14486
5.22 ±	14486
1.07	14493
10.58 ± 3.11	14499
10.58	14499
3.11	14507
and 1.5	14513
0.379	14523
There	14544
a signifi cant difference	14554
the OM and PBS transplanted groups -LRB- * P < 0.05 -RRB-	14588
the OM and PBS transplanted groups	14588
P <	14626
P	14626
<	14628
0.05	14630
OM transplantation	14637
good support of axonal regeneration	14666
good support	14666
axonal regeneration	14682
a scaffold	14705
OM	14717
olfactory mucosa	14730
BDA , biotinylated dextran amine	14748
BDA	14748
dextran amine	14766
RM , respiratory mucosa	14781
RM	14781
respiratory mucosa	14785
WGA , wheat germ agglutinin	14805
WGA	14805
wheat germ agglutinin	14810
PBS , phosphate-buffered saline	14833
PBS	14833
phosphate-buffered saline	14838
-LRB- 3F -RRB-	14865
The number	14872
retrograde tracer WGA-positive dots at area -LRB- a -RRB-	14894
retrograde tracer WGA-positive dots	14894
area	14933
, Figure 3C -RRB-	14949
3C	14958
which	14964
the epicenter	14985
RM -LRB- n = 9 -RRB- , OM -LRB- n = 18 -RRB- , and PBS -LRB- n = 9 -RRB- groups	15015
RM -LRB- n = 9 -RRB-	15015
RM	15015
n	15019
9	15023
OM -LRB- n = 18 -RRB-	15027
OM	15027
n	15031
18	15035
PBS -LRB- n = 9 -RRB- groups	15044
PBS	15044
n	15049
9	15053
groups	15056
4.88 ± 1.37	15067
4.88	15067
1.37	15074
17.77 ± 1.7	15080
17.77	15080
1.7	15088
and 1.77	15093
0.641	15104
OM transplantation	15125
the number of WGA-positive dots	15154
the number	15154
WGA-positive dots	15168
RM and PBS groups -LRB- † P < 0.01 -RRB-	15200
RM	15200
PBS groups -LRB- † P < 0.01 -RRB-	15207
PBS groups	15207
† P < 0.01	15219
† P	15219
< 0.01	15223
<	15223
0.01	15225
OM transplantation	15232
good support of axonal regeneration	15272
good support	15272
axonal regeneration	15288
producing relay-neurons	15311
OM	15336
olfactory mucosa	15349
WGA , wheat germ agglutinin	15367
WGA	15367
wheat germ agglutinin	15372
RM , respiratory mucosa	15395
RM	15395
respiratory mucosa	15399
PBS , phosphate-buffered saline Figure 4	15419
PBS	15419
phosphate-buffered saline Figure 4	15424
phosphate-buffered saline Figure	15424
4	15458
A , Confocal imaging of OM transplantation at area	15461
, Confocal imaging of OM transplantation	15463
, Confocal imaging	15463
OM transplantation	15485
b	15514
the injured spinal cord -LRB- scale bar = 400 μ m -RRB-	15521
the injured spinal cord	15521
scale bar = 400 μ m	15546
scale bar = 400	15546
scale bar	15546
400	15558
μ m	15562
Spinal cord sections of area -LRB- b -RRB-	15568
Spinal cord sections of area	15568
Spinal cord sections	15568
area	15592
b	15599
EGFP -LRB- green -RRB-	15621
EGFP	15621
WGA -LRB- gray -RRB-	15635
WGA	15635
BDA -LRB- red -RRB-	15647
BDA	15647
DAPI -LRB- blue -RRB-	15662
DAPI	15662
blue	15668
There	15675
a WGA and BDA-positive cell -LRB- yellow arrow head -RRB-	15685
a WGA and BDA-positive cell	15685
yellow arrow head	15714
the red square -LRB- I -RRB-	15736
the red square	15736
I	15752
this high magnifi cation image	15760
red square , scale bar = 50 μ m	15801
red square	15801
scale bar = 50 μ m	15813
scale bar	15813
= 50 μ m	15823
50	15825
addition	15837
there	15847
quadruple-positive cells -LRB- red and white arrow -RRB-	15858
quadruple-positive cells	15858
red and white arrow	15884
red	15884
white arrow	15892
the white square -LRB- II -RRB- and the yellow square -LRB- III -RRB-	15908
the white square	15908
II	15926
the yellow square	15934
III	15953
each of these high magnifi	15963
each	15963
these high magnifi	15971
cation images	15990
each line square , scale bar = 50 μ m	16014
each line square	16014
scale bar = 50 μ m	16032
scale bar	16032
= 50 μ m	16042
50	16044
B	16053
Relay-neurons	16057
OM-transplanted tissue	16084
area -LRB- b -RRB- , injured spinal cord	16110
area -LRB- b -RRB-	16110
area	16110
b	16116
injured spinal cord	16120
Type I cell	16141
Type	16141
I cell	16146
WGA and BDA	16157
This cell	16179
regenerated axons	16199
rostral neurons	16222
Type II and III cells	16239
Type II	16239
III cells	16251
EGFP , WGA , BDA , and DAPI positive	16266
EGFP	16266
WGA	16272
BDA	16277
DAPI positive	16286
These cells	16301
relay-neurons	16323
Scale bar	16338
20 μ m. C , The number of counted quadruple-positive cells	16350
20 μ m. C	16350
The number of counted quadruple-positive cells	16362
The number	16362
counted quadruple-positive cells	16376
area -LRB- b -RRB- injured spinal cord	16412
area -LRB- b -RRB-	16412
area	16412
b	16418
injured spinal cord	16421
These EGFP , WGA , BDA , and DAPI-positive cells	16442
These EGFP	16442
WGA	16454
BDA	16459
DAPI-positive cells	16468
OM-transplanted rats	16509
P <	16533
P	16533
<	16535
0.01	16537
OM transplantation	16544
relay-neurons	16575
injured spinal cord	16592
OM , n = 24 ; RM , n = 15 .	16613
OM , n = 24	16613
OM	16613
n = 24	16617
n	16617
24	16621
RM , n = 15	16625
RM	16625
n = 15	16629
n	16629
15	16633
OM	16637
olfactory mucosa	16650
BDA	16668
dextran amine	16686
WGA , wheat germ agglutinin	16701
WGA	16701
wheat germ agglutinin	16706
RM , respiratory mucosa ; EGFP ,	16729
RM	16729
respiratory mucosa ; EGFP	16733
respiratory mucosa	16733
EGFP	16753
green fl	16768
uorescent protein DAPI , 4	16777
uorescent protein DAPI	16777
4	16801
Figure 5 .	16833
Figure	16833
5	16840
relay-neurons	16850
there	16865
synapses between regenerated axons and relay-neurons derived from OM tissue	16876
synapses	16876
regenerated axons and relay-neurons derived from OM tissue	16893
regenerated axons and relay-neurons	16893
OM tissue	16942
Line I	16953
relay-neurons	16975
Line II or III	16990
Line	16990
or just relay-neurons	17013
OM	17036
olfactory mucosa	17049
Quantifi cation of Axons Regenerated	17068
Quantifi cation	17068
Axons Regenerated	17087
Epicenter	17113
Anterograde BDA Axonal regeneration	17126
the epicenter from rostral	17170
the epicenter	17170
rostral	17189
caudal spinal sites	17200
quantifi	17224
BDA-positive axons	17248
the dorsal column	17270
both cervical -LRB- area a -RRB- and lower thoracic portions -LRB- area c -RRB-	17291
both cervical -LRB- area a -RRB- and lower thoracic portions	17291
cervical -LRB- area a -RRB-	17296
cervical	17296
area a	17306
lower thoracic portions	17318
area c	17343
10 weeks	17351
transplantation	17366
BDA-positive cells	17383
intramedullary spinal cord	17424
Figure 3A , B	17452
Figure 3A	17452
B	17463
confocal microscope images	17471
typical sections	17501
both cervical -LRB- area a -RRB- and lower thoracic portions -LRB- area c -RRB-	17521
both cervical -LRB- area a -RRB-	17521
both cervical	17521
area a	17536
lower thoracic portions -LRB- area c -RRB-	17548
lower thoracic portions	17548
area c	17573
OM tissue transplants labeled with BDA	17586
OM tissue transplants	17586
BDA	17621
BDA-positive dots -LRB- red dots in Figure 3A , B -RRB-	17626
BDA-positive dots	17626
red dots in Figure 3A , B	17645
red dots	17645
Figure 3A	17657
B	17668
the dorsal column	17693
axonal regeneration	17727
OM , RM ,	17764
OM	17764
RM	17768
spinal cord tissue	17786
the mild SCI rats	17809
there	17828
axons	17851
endogenous axons	17868
the epicenter	17892
BDA	17918
the epicenter along regenerated axons and the remaining endogenous axons	17939
the epicenter	17939
regenerated axons and the remaining endogenous axons	17959
regenerated axons	17959
the remaining endogenous axons	17981
the number of BDA-positive dots	18022
the number	18022
BDA-positive dots	18036
the tissue transplants	18069
the quantitative analysis in Figure 3E	18109
the quantitative analysis	18109
Figure 3E	18138
The number	18150
BDA-positive dots	18164
the dorsal column of area	18185
the dorsal column	18185
area	18206
c	18212
inferior from the epicenter , for RM , OM	18216
the epicenter	18230
RM	18249
PBS	18261
5.22 ± 1.07 , 10.58 ± 3.11 , and 1.5 ± 0.379	18269
5.22 ± 1.07	18269
5.22 ±	18269
1.07	18276
10.58 ± 3.11	18282
10.58	18282
3.11	18290
1.5 ± 0.379	18300
1.5	18300
0.379	18306
area -LRB- a -RRB- , superior from the epicenter	18339
area -LRB- a -RRB-	18339
area	18339
a	18345
the epicenter	18363
there	18378
no signifi cant differences	18389
RM	18425
OM	18429
PBS	18437
92 ± 25.15 , 155 ± 16.67 , and 129 ± 26.87 , respectively	18442
92 ± 25.15	18442
92	18442
25.15	18447
155 ± 16.67	18454
155	18454
16.67	18460
129 ± 26.87 , respectively	18471
129 ± 26.87	18471
129	18471
26.87	18477
Figure 2	18511
each rat	18526
three 2-mm thick sections	18536
area -LRB- a -RRB- and -LRB- c -RRB-	18575
area -LRB- a -RRB-	18575
area	18575
a	18581
-LRB- c -RRB-	18588
Total counted samples were RM , n = 9 ; OM , n = 18 ; and PBS , n	18593
Total counted samples were RM	18593
Total	18593
samples	18607
RM	18620
n = 9	18624
n	18624
9	18628
OM , n = 18	18631
OM	18631
n = 18	18635
n	18635
18	18639
PBS , n	18647
PBS	18647
n	18652
9	18656
the exception	18664
broken sections	18681
These data	18698
OM transplantation	18724
axonal regeneration	18753
Count of Axons Regenerated	18774
Count	18774
Axons Regenerated	18783
Epicenter	18809
Retrograde Trans-synaptic WGA Axonal regeneration	18822
trans-synaptic reconstruction	18882
quantifi	18917
WGA-positive axons	18941
the dorsal column	18963
the spinal cord	18984
both cervical -LRB- area a -RRB- and lower thoracic portions -LRB- area c -RRB-	19003
both cervical -LRB- area a -RRB- and lower thoracic portions	19003
cervical -LRB- area a -RRB-	19008
cervical	19008
area a	19018
lower thoracic portions	19030
area c	19055
10 weeks	19063
transplantation	19078
WGA-positive cells and tissues	19095
both intramedullary and extramedullary spinal cord including pia , dura mater ,	19143
both intramedullary and extramedullary spinal cord	19143
pia , dura mater ,	19204
pia	19204
dura mater	19209
the dorsal column	19241
WGApositive dots	19260
axonal regeneration	19287
endogenous neurons	19315
relay-neurons	19343
the epicenter from caudal to rostral sites	19365
the epicenter	19365
caudal to rostral sites	19384
Figure 3C , and D	19409
Figure 3C	19409
D	19424
typical sections	19431
the cervical -LRB- area a -RRB-	19456
the cervical	19456
area a	19470
lower thoracic -LRB- area c -RRB- regions	19482
area c	19498
WGA -LRB- shown in gray -RRB-	19537
WGA	19537
WGA-positive dots -LRB- gray -RRB- in the dorsal column	19558
WGA-positive dots -LRB- gray -RRB-	19558
WGA-positive dots	19558
the dorsal column	19586
axonal regeneration	19611
endogenous	19639
relay-neurons	19659
WGA	19681
a trans-synaptic tracer	19689
Figure 3F	19717
the number of WGA-positive dots at area -LRB- a -RRB-	19729
the number of WGA-positive dots at area	19729
the number	19729
WGA-positive dots at area	19743
WGA-positive dots	19743
area	19764
the number	19793
WGA-positive dots	19815
the dorsal column	19836
area	19857
-LRB- a -RRB- superior from the epicenter for RM , OM , and PBS	19862
-LRB- a -RRB- superior from the epicenter for RM	19862
superior	19866
the epicenter for RM	19880
the epicenter	19880
RM	19898
OM	19902
PBS	19910
4.88 ± 1.37 , 17.77 ± 1.7 , and 1.77 ± 0.641	19919
4.88 ± 1.37	19919
4.88	19919
1.37	19926
17.77 ± 1.7	19932
17.77	19932
1.7	19940
1.77 ± 0.641	19949
1.77	19949
0.641	19956
Figure 3F	19978
area -LRB- c -RRB- , inferior from the epicenter	19994
area	19994
c	20000
the epicenter	20018
there	20033
no signifi cant differences	20044
RM	20080
OM	20084
PBS	20092
80.4 ± 19.1 , 84.41 ± 11.72 , and 72.75 ± 11.03 , respectively	20097
80.4 ± 19.1	20097
80.4	20097
19.1	20104
84.41 ± 11.72	20110
84.41	20110
11.72	20118
72.75 ± 11.03 , respectively	20129
72.75 ± 11.03	20129
72.75	20129
11.03	20137
Figure 2	20171
each rat	20182
three 2-mm thick sections at area -LRB- a -RRB- and -LRB- c -RRB-	20195
three 2-mm thick sections	20195
area -LRB- a -RRB- and -LRB- c -RRB-	20224
area -LRB- a -RRB-	20224
area	20224
a	20230
-LRB- c -RRB-	20237
Total counted samples were RM , n = 9 ; OM , n = 18 ; and PBS , n	20242
Total counted samples were RM	20242
Total	20242
samples	20256
RM	20269
n = 9	20273
n	20273
9	20277
OM , n = 18	20280
OM	20280
n = 18	20284
n	20284
18	20288
PBS , n	20296
PBS	20296
n	20301
9	20305
the exception	20313
broken sections	20330
Transplantation of OM	20347
Transplantation	20347
OM	20366
the greatest axonal regeneration	20379
the point of both endogenous neurons	20417
the point	20417
both endogenous neurons	20430
relay-neurons	20463
RM and PBS transplantation	20482
signifi cantly less numbers of WGA-positive axons	20519
signifi cantly less numbers	20519
WGA-positive axons	20550
Relay-Neurons Derived	20570
Transplanted Tissue To confi rm	20597
rm	20626
the presence of relay-neurons derived from transplanted tissues	20629
the presence	20629
relay-neurons derived from transplanted tissues	20645
relay-neurons	20645
transplanted tissues	20672
double labeling of axons using WGA and BDA through the epicenter	20694
double labeling	20694
axons using WGA and BDA through the epicenter	20713
axons	20713
WGA and BDA	20725
the epicenter	20745
thoracic-injured and transplanted portions -LRB- area b -RRB-	20777
thoracic-injured	20777
transplanted portions -LRB- area b -RRB-	20798
transplanted portions	20798
area b	20821
EGFP , DAPI , WGA , and BDA-positive cells	20830
EGFP	20830
DAPI	20836
WGA	20842
BDA-positive cells	20851
OM - and RM-transplanted rats	20884
confocal microscopy	20919
Figure 4A	20940
the confocal microscope images	20956
typical sections transplanted with OM tissue derived from EGFP rats	20990
typical sections	20990
OM tissue derived from EGFP rats	21025
OM tissue	21025
EGFP rats	21048
There	21059
several EGFPpositive cells	21070
other positive pattern cells in OM	21100
other positive pattern cells	21100
OM	21132
RMtransplanted portions -LRB- area b -RRB-	21139
RMtransplanted portions	21139
area b	21164
These cells around relay-neurons	21173
These cells	21173
relay-neurons	21192
classifi ed into the 3 cells types in Figure 5	21211
classifi	21211
the 3 cells types	21228
Figure 5	21249
Cells cut at the I-line of Figure 5	21260
Cells	21260
the I-line of Figure 5	21273
the I-line	21273
Figure 5	21287
regenerated axons	21303
superior endogenous neurons	21326
they	21362
WGA and BDA-positive -LRB- Figure 4B-I -RRB-	21372
WGA	21372
BDA-positive -LRB- Figure 4B-I -RRB-	21380
BDA-positive	21380
Figure 4B-I	21395
Cells that were cut at the II and III line in Figure 5	21410
Cells	21410
the II and III line	21433
Figure 5	21456
just relay-neurons	21472
axon terminals and synapses -LRB- Figure 4B-II , III -RRB-	21496
axon terminals and synapses	21496
Figure 4B-II	21526
III	21540
An especially interesting cell type	21547
EGFP-positive	21596
DAPI , WGA , and BDA-positive -LRB- Figure 4B-II -RRB-	21619
DAPI , WGA , and BDA-positive	21619
DAPI	21619
WGA	21625
BDA-positive	21634
Figure 4B-II	21649
This quadruple-positive cell	21665
the relay-neuron derived from OM-transplanted tissue	21698
the relay-neuron	21698
OM-transplanted tissue	21728
The number of EGFP-positive cells in RM and OM	21752
The number	21752
EGFP-positive cells in RM and OM	21766
EGFP-positive cells	21766
RM and OM	21789
signifi cantly different -LRB- 21.8 ± 4.35 and 22.83 ± 2.5 , respectively -RRB-	21808
signifi	21808
21.8 ± 4.35 and 22.83 ± 2.5 , respectively	21834
21.8 ± 4.35 and 22.83 ± 2.5	21834
21.8 ± 4.35	21834
21.8	21834
4.35	21841
22.83 ± 2.5	21850
22.83	21850
2.5	21858
the number of quadruple-positive cells	21887
the number	21887
quadruple-positive cells	21901
OM tissue rats -LRB- RM , 0.133 ± 0.09 ; and OM , 2.33 ± 0.509 -RRB-	21958
OM tissue rats -LRB- RM , 0.133 ± 0.09 ; and OM	21958
OM tissue rats -LRB- RM , 0.133 ± 0.09 ;	21958
OM tissue rats	21958
RM	21974
0.133 ± 0.09	21978
0.133	21978
0.09	21986
OM	21996
2.33 ± 0.509	22000
2.33	22000
0.509	22007
Figure 4C	22016
Figure 2	22041
each rat	22052
fi	22065
2-mm thick sections	22071
area -LRB- b -RRB-	22094
area	22094
b	22100
Total counted samples	22104
Total	22104
samples	22118
RM , n = 15 and OM , n = 24	22131
RM	22131
n = 15	22135
n	22135
15	22139
OM , n = 24	22146
OM	22146
n = 24	22150
n	22150
24	22154
the exception	22163
broken sections , which we could not investigate because of their partial defect	22180
broken sections	22180
we	22203
their partial defect	22239
OM tissue	22274
relay-neurons	22293
the injured spinal cord	22310
neuronal pathways	22349
DISCUSSION Previous research	22369
OM tissue transplantation	22420
an obvious effect on SCI	22450
an obvious effect	22450
SCI	22471
axons	22492
SCI	22506
confi rmed using BDA tracer	22520
confi	22520
BDA tracer	22537
3 , 7 Iwatsuki et al 3 and Aoki et al 7	22549
3	22549
7 Iwatsuki et al 3 and Aoki et al 7	22553
7 Iwatsuki	22553
et al 3 and Aoki et al 7	22564
et al 3	22564
et al	22564
3	22570
Aoki et al 7	22576
Aoki	22576
et al	22581
7	22587
this slight axonal regeneration	22608
functional recovery in the hind limbs	22654
functional recovery	22654
the hind limbs	22677
the retrograde tracer WGA	22699
we	22726
OM transplantation	22747
the relay-neurons resulting in the reconstruction of neuronal pathways	22785
the relay-neurons	22785
the reconstruction of neuronal pathways	22816
the reconstruction	22816
neuronal pathways	22838
Axonal Regeneration We	22857
the effectiveness of OM tissue transplantation	22889
the effectiveness	22889
OM tissue transplantation	22910
axonal regeneration using dual neuronal tracing	22939
axonal regeneration	22939
dual	22965
24	22988
Figure 3E	22994
BDA-positive dots	23006
area -LRB- c -RRB-	23047
area	23047
c	23053
the epicenter in OM tissue against PBS	23064
the epicenter	23064
OM tissue against PBS	23081
OM tissue	23081
PBS	23099
this study	23107
BDA-positive dots	23119
axonal fi bers	23146
both remaining	23166
axons	23197
Figure 3F	23220
WGApositive dots	23232
signifi	23270
area	23288
OM transplantation compared with RM and PBS transplantation	23303
OM transplantation	23303
RM and PBS transplantation	23336
These dots	23364
trans-synaptic regeneration	23400
the epicenter	23436
OM tissue	23464
axonal regeneration	23483
trans-synaptic regeneration as a scaffold and as a source of relay-neurons	23513
trans-synaptic regeneration	23513
a scaffold	23544
a source of relay-neurons	23562
a source	23562
relay-neurons	23574
Relay-Neurons	23589
WGA	23611
a retrograde trans-synaptic tracer	23618
the relay-neurons	23657
transplantation tissues presented in the injured portion	23688
transplantation tissues	23688
the injured portion	23725
WGA tracer	23746
the injected portion of area -LRB- d -RRB-	23777
the injected portion	23777
area -LRB- d -RRB-	23801
area	23801
d	23807
area -LRB- a -RRB- through the epicenter of area -LRB- b -RRB-	23813
area -LRB- a -RRB- through the epicenter of area	23813
area	23813
-LRB- a -RRB- through the epicenter of area	23818
through the epicenter	23822
area	23847
b	23853
We	23857
the presence of relayneurons	23882
the presence	23882
relayneurons	23898
the number of WGA-positive dots	23926
the number	23926
WGA-positive dots	23940
area -LRB- a -RRB- -LRB- Figure 3F -RRB-	23961
area -LRB- a -RRB-	23961
area	23961
a	23967
Figure 3F	23972
OM tissue	23998
relayneurons to reconstruct axonal pathways	24018
axonal pathways	24046
RM tissue	24096
We	24107
the presence of relay-neurons	24132
the presence	24132
relay-neurons	24148
OM tissue using confocal microscope images	24167
OM tissue	24167
confocal microscope images	24183
injured and transplanted portions of area -LRB- b -RRB-	24214
injured and transplanted portions	24214
area -LRB- b -RRB-	24251
area	24251
b	24257
there	24261
some EGFP-positive cells -LRB- Figure 4A -RRB-	24272
some EGFP-positive cells	24272
Figure 4A	24299
these EGFP-positive cells	24318
there	24345
a few WGA , BDA , and DAPI-positive cells -LRB- Figure 4B -RRB-	24356
a few WGA	24356
BDA	24367
DAPI-positive cells -LRB- Figure 4B -RRB-	24376
DAPI-positive cells	24376
Figure 4B	24398
These quadruple-positive cells	24411
the relay-neurons derived from transplanted OM tissue	24447
the relay-neurons	24447
transplanted OM tissue	24478
relay-neurons	24509
there	24524
synapses between regenerated axons and relay-neurons	24535
synapses	24535
regenerated axons and relay-neurons	24552
Figure 5 shows examples of the cut surface .	24589
Figure 5 shows	24589
examples of the cut surface	24604
examples	24604
the cut surface	24616
These quadruple cells , like those shown in Figure 4B-II or III ,	24633
These quadruple cells	24633
those shown in Figure 4B-II or III	24661
those	24661
Figure 4B-II or III	24676
signifi cantly more in OM rats -LRB- Figure 4C -RRB-	24711
signifi	24711
OM rats	24734
Figure 4C	24744
Recent studies of spinal cord axonal regeneration	24757
Recent studies	24757
spinal cord axonal regeneration	24775
good longterm results	24821
various types of tissue scaffolds	24849
various types	24849
tissue scaffolds	24866
17 , 19 Olfactory tissue in particular ,	24884
17	24884
19 Olfactory tissue in particular	24889
19 Olfactory tissue	24889
particular	24912
autologous transplantation	24931
a simple biopsy 31 performed through the external nares	25004
a simple biopsy 31	25004
the external nares	25041
The OM	25061
an excellent autologous source of adult neuronal precursor cells	25080
an excellent autologous source	25080
adult neuronal precursor cells	25114
It	25146
neurons and sustentacular cells that renew themselves throughout one 's lifetime	25158
neurons	25158
sustentacular cells that renew themselves throughout one 's lifetime	25170
sustentacular cells	25170
themselves	25201
one 's lifetime	25223
one 's	25223
32 -- 34 Furthermore	25239
32 -- 34	25239
we	25258
rm the relay-neurons derived from OM	25273
rm	25273
the relay-neurons	25276
OM	25307
These considerations , combined with the results of this study ,	25311
These considerations	25311
the results of this study	25347
the results	25347
this study	25362
OM	25379
an attractive potential scaffold for axonal regeneration	25382
an attractive potential scaffold	25382
axonal regeneration	25419
Transplantation of OM	25440
Transplantation	25440
OM	25459
many advantages	25466
part	25499
functional and structural restoration	25514
SCI	25558
this study	25566
we	25578
one of the proposed mechanisms of OM transplantation	25592
one	25592
the proposed mechanisms of OM transplantation	25599
the proposed mechanisms	25599
OM transplantation	25626
SCI	25648
the presence of relay-neurons	25668
the presence	25668
relay-neurons	25684
axonal regeneration	25715
